(Q46928150)

26 December 2017

title

Notoginsenoside R1 from Panax notoginseng inhibits TNF-alpha-induced PAI-1 production in human aortic smooth muscle cells (English)

1 reference

26 December 2017

0 references

1 reference

Hong-Sheng Zhang

1

1 reference

26 December 2017

Sheng-Qi Wang

series ordinal

2

1 reference

26 December 2017

publication date

3 February 2006

1 reference

26 December 2017

published in

Vascular Pharmacology

1 reference

26 December 2017

volume

44

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

224-230

1 reference

26 December 2017

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

The plasminogen activator system: biology and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen-activator inhibitor type 1 and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen Activator Expression in Human Atherosclerotic Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Quantification of Plasminogen Activators and Their Inhibitors in the Aortic Vessel Wall in Relation to the Presence and Severity of Atherosclerotic Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.002

10.1016/J.VPH.2005.12.002

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017